Asston Pharmaceuticals Limited (BOM:544445)
India
· Delayed Price · Currency is INR 78.00
-2.50 (-3.11%)
At close: Mar 9, 2026
Asston Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Net Income | - | 43.25 | 13.6 | 10.57 | 1.11 | 0.92 | Upgrade
|
| Depreciation & Amortization | - | 0.81 | 0.51 | 0.37 | 0.08 | 0.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.56 | - | - | - | - | Upgrade
|
| Other Operating Activities | - | 22.78 | 8.98 | 10.52 | 4.5 | 1.2 | Upgrade
|
| Change in Accounts Receivable | - | -83.98 | -75.43 | -22.09 | -21.66 | -32.98 | Upgrade
|
| Change in Inventory | - | 7.22 | 0.62 | -9.98 | 7.29 | -6.57 | Upgrade
|
| Change in Accounts Payable | - | 0.52 | 2.7 | 10.14 | 1.84 | 32.92 | Upgrade
|
| Change in Other Net Operating Assets | - | 8.33 | 11.02 | -2.68 | -5.02 | -2.96 | Upgrade
|
| Operating Cash Flow | - | -1.63 | -38 | -3.16 | -11.86 | -7.31 | Upgrade
|
| Capital Expenditures | - | - | -0.1 | -2.51 | -0.02 | -9.32 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.11 | - | - | - | - | Upgrade
|
| Investment in Securities | - | 7.09 | -0.35 | -6.73 | - | - | Upgrade
|
| Other Investing Activities | - | 0.49 | 0.4 | 0.12 | 0 | 0.2 | Upgrade
|
| Investing Cash Flow | - | 8.68 | -0.05 | -9.12 | -0.02 | -9.12 | Upgrade
|
| Short-Term Debt Issued | - | - | 17.66 | 10.57 | 23.69 | - | Upgrade
|
| Long-Term Debt Issued | - | 6.3 | - | 8.78 | - | 15.2 | Upgrade
|
| Total Debt Issued | - | 6.3 | 17.66 | 19.36 | 23.69 | 15.2 | Upgrade
|
| Short-Term Debt Repaid | - | -1.93 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -1.92 | - | -13.33 | -1.4 | Upgrade
|
| Total Debt Repaid | - | -1.93 | -1.92 | - | -13.33 | -1.4 | Upgrade
|
| Net Debt Issued (Repaid) | - | 4.37 | 15.75 | 19.36 | 10.36 | 13.81 | Upgrade
|
| Issuance of Common Stock | - | - | 30.46 | - | 6.9 | - | Upgrade
|
| Other Financing Activities | - | -9.5 | -9.33 | -7.21 | -4.34 | -1.21 | Upgrade
|
| Financing Cash Flow | - | -5.13 | 36.88 | 12.15 | 12.93 | 12.6 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | 0 | 0 | - | Upgrade
|
| Net Cash Flow | - | 1.93 | -1.17 | -0.13 | 1.04 | -3.82 | Upgrade
|
| Free Cash Flow | - | -1.63 | -38.11 | -5.67 | -11.89 | -16.62 | Upgrade
|
| Free Cash Flow Margin | - | -0.65% | -24.45% | -8.67% | -12.38% | -20.69% | Upgrade
|
| Free Cash Flow Per Share | - | -0.26 | -6.80 | -1.01 | -124.88 | -207.77 | Upgrade
|
| Cash Interest Paid | - | 9.5 | 9.33 | 7.21 | 4.34 | 1.21 | Upgrade
|
| Cash Income Tax Paid | - | -0.03 | 4.52 | 0.13 | 0.32 | 0.08 | Upgrade
|
| Levered Free Cash Flow | - | -18.39 | -57.54 | -18.64 | -9.74 | -17.72 | Upgrade
|
| Unlevered Free Cash Flow | - | -13.41 | -51.91 | -14.42 | -7.08 | -17.21 | Upgrade
|
| Change in Working Capital | - | -67.91 | -61.09 | -24.61 | -17.55 | -9.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.